Positions
- Section Chief of Nephrology
-
Baylor College of Medicine
Houston, Texas, United States
- Gordon A. Cain Chair in Nephrology
-
Medicine
Nephrology
Baylor College of Medicine
United States
- Professor
-
Baylor College of Medicine
Addresses
- Alkek Building for Biomedical Research (Office)
-
Room: ABBR-R705
Houston, TX, 77030
United States
Phone: (713) 798-2625
winkelma@bcm.edu
Professional Interests
- Inpatient kidney health care; health policy; evidence based medicine and guidelines; medical publishing; faculty development
Professional Statement
Dr. Wolfgang Winkelmayer is a Professor of Medicine, holds the Gordon A. Cain Chair in Nephrology, and serves as Chief of the Section of Nephrology at Baylor College of Medicine in Houston.
Originally from Vienna, Austria, where he received his medical education, he earned a Master of Public Health degree in Health Care Management (1999) and a Doctor of Science degree in Health Policy (2001) from Harvard University. He then spent eight years on the faculty of Brigham and Women¹s Hospital and Harvard Medical School where he established himself as a prolific investigator and leader in the discipline of comparative-effectiveness research as it pertains to kidney disease. Before joining Baylor in 2014, he spent five years at Stanford University where he was the Director of Clinical Research in the Division of Nephrology. His main areas of research interest include the treatment of anemia as well as the effectiveness and safety of interventions for cardiovascular disease in patients with kidney disease.
From 2016 to 2023, he served as Co-Chair of Kidney Disease: Improving Global Outcomes (KDIGO), the leading guideline group in nephrology. In addition, he has particular interest in medical publishing. He served as a Co-Editor of the American Journal of Kidney Disease from 2007 to 2016, as an Associate Editor for Nephrology for JAMA, The Journal of the American Medical Association, from 2012 to 2026, and has been appointed to several other editorial boards of leading nephrology and epidemiology journals. In 2027, he will become the Editor-in-Chief of the American Journal of Kidney DIseases.
Originally from Vienna, Austria, where he received his medical education, he earned a Master of Public Health degree in Health Care Management (1999) and a Doctor of Science degree in Health Policy (2001) from Harvard University. He then spent eight years on the faculty of Brigham and Women¹s Hospital and Harvard Medical School where he established himself as a prolific investigator and leader in the discipline of comparative-effectiveness research as it pertains to kidney disease. Before joining Baylor in 2014, he spent five years at Stanford University where he was the Director of Clinical Research in the Division of Nephrology. His main areas of research interest include the treatment of anemia as well as the effectiveness and safety of interventions for cardiovascular disease in patients with kidney disease.
From 2016 to 2023, he served as Co-Chair of Kidney Disease: Improving Global Outcomes (KDIGO), the leading guideline group in nephrology. In addition, he has particular interest in medical publishing. He served as a Co-Editor of the American Journal of Kidney Disease from 2007 to 2016, as an Associate Editor for Nephrology for JAMA, The Journal of the American Medical Association, from 2012 to 2026, and has been appointed to several other editorial boards of leading nephrology and epidemiology journals. In 2027, he will become the Editor-in-Chief of the American Journal of Kidney DIseases.
Log In to edit your profile